Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

A new bone marrow imaging technique could change treatment for cancer, autoimmune disease and musculoskeletal disorders.

Chad Royer, longtime community advocate, who is a member of Bronx Board (CB7) and the chair of the CB7 veterans committee, ...

It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely die from the ...

Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

India Bone Marrow Transplantation Market Size Expands at Steady CAGR 4.76% to Touch USD 1.3 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...

GSK’s Blenrep is the only B-cell maturation antigen (BCMA)-targeted antibody-drug conjugate for multiple myeloma, offering ...

For Townsville couple Darryl and Lauran Baillie, a detection machine would have meant Ms Baillie’s rare form of bone marrow ...

For Townsville couple Darryl and Lauren Bailey, a detection machine would have meant Ms Bailey’s rare form of bone marrow ...

Legend Biotech (LEGN) shares jumped 5% over the past week on heavy trading volume as investors responded to impressive ...